Cause of death, by non-communicable diseases, ages 15-59, female in Japan
Japan: Cause of death, by non-communicable diseases, ages 15-59, female was 79.1% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 15-59, female in Japan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 15-59.
Analysis
Japan recorded 79.1% for cause of death, by non-communicable diseases, ages 15-59, female in 2021.
Compared with earlier readings it is down 1.0% on the previous year and up 2.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, female in Japan peaked at 81.4% in 2019 and was at its lowest, 77.4%, in 2010.
Japan ranks 28th of 185 countries on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 15-59, female in Japan, year by year
| Year | % of total female deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 78.2% | — |
| 2010 | 77.4% | -1.0% |
| 2015 | 79.0% | +2.1% |
| 2019 | 81.4% | +3.0% |
| 2020 | 79.9% | -1.9% |
| 2021 | 79.1% | -1.0% |
Japan compared with similar countries
- Japan's 79.1% is above the median for high income countries, which is 76.1%, 1.0× the median. (58 countries reporting)
- Japan's 79.1% is above the median for East Asia & Pacific, which is 73.7%, 1.1× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 78.2% | 78.2% | 78.2% | 1 |
| 2010s | 79.3% | 77.4% | 81.4% | 3 |
| 2020s | 79.5% | 79.1% | 79.9% | 2 |
Countries ranked near Japan
More health data for Japan
- Un projection of annual infant deaths, annual growth rate -2.73 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2774 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,294 deaths per 1,000 people (2090)
- Number of infants who die before age 1 178 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0155 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, female in Japan?
- Cause of death, by non-communicable diseases, ages 15-59, female in Japan was 79.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, female recorded in Japan?
- The highest recorded value was 81.4% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, female recorded in Japan?
- The lowest recorded value was 77.4% in 2010.
- How does Japan rank for cause of death, by non-communicable diseases, ages 15-59, female?
- Japan ranks 28th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, female rising or falling in Japan?
- Over the last ten years it is up 2.1%. The long-run trend across the full record is flat.
- Where does this Japan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.